SOLICITATION NOTICE
A -- Services
- Notice Date
- 9/17/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 1062232
- Archive Date
- 10/3/2009
- Point of Contact
- William T. Lee, Phone: 3014435863, Doreen Williams,
- E-Mail Address
-
william.lee@fda.hhs.gov, doreen.williams@fda.hhs.gov
(william.lee@fda.hhs.gov, doreen.williams@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6, simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-35. This solicitation is issued as a Request for Proposal (RFQ). This announcement constitutes the only solicitation and a written solicitation will not be issued. This synopsis, NAICS code 541380, is to notify contractors that the government intends to issue a Purchase Order in accordance with FAR Part 13.106 for the following specifications, under the simplified acquisition procedures. This solicitation is posted 100% Total Small business to all qualified small businesses and will be awarded as a Firm Fixed Price Purchase Order. Prospective offerors are responsible for downloading the solicitation and any amendments. It is the offeror's responsibility to monitor the FedBizOpps website for the release of any amendments to this solicitation. The Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. The Center for Drug Evaluation and Research (CDER) has requested Elemental Analysis Services for one year to assist in biodistribution studies of nanoparticles and nanoparticle constructs. Project Title: Determining the effect of delivery medium and surface chemistry on the biodistribution of nanoparticles in in-vivo and in-vitro models. Description of Work: The contractor will be required to provide the following services in performance of the requirements of the Statement of Work: a)Inductively coupled plasma mass spectrometry (ICP-MS) and/or neutron activation analysis (NAA) preparation, standardization, and analysis of test materials (including delivery materials) and murine models (including tissues, blood faces, and urine). The analysis will provide elemental analysis of the specified element with ppb sensitivity (dependent upon sample mass). Since the ICP-MS and/or NAA analysis to be completed is dependent upon the results found from previous and ongoing studies, only an estimate of the types of elements and tissue numbers required are submitted for cost purposes in awarding the contract. To require the investigators to use these estimates as concrete requirements, without allowing them some flexibility to change the numbers and types of samples following the results from the pilot study, will not provide the service that is needed. Please note that the pilot study will consist of gold particles and roughly 500 samples to be exceeded and any requests will be closely monitored to assure this does not happen. The estimated samples and numbers for the cost estimating follow: ItemQuantityUnit Sample Preparation30ea Elemental analysis Au500ea Elemental analysis Cd100ea Elemental analysis Mg100ea Elemental analysis Si100ea Elemental analysis Ti100ea Elemental analysis Ag100ea. FOB: Destination DELIVERY SCHEDULE: 30 days after award DELIVERY LOCATION: White Oak Campus, Bldg 64 10903 New Hampshire Avenue Silver Spring, MD 20993 EVALUATION AND AWARD: The Government intends to evaluate proposals however; the Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. The award will be made to the offeror whose proposal conforms to the terms and conditions of the solicitation under a Firm Fixed Price Purchase Order. Evaluation for Award: The award will be made to the party whose quote offers the best value to the government, technical and price. The Government may award this purchase order to other than the lowest priced technically acceptable quote. The Government will evaluate information based on the following evaluation criteria: 1) Technical Capability factor “Meeting or Exceeding the Technical Requirements”; 2) Price. Meeting the Technical Requirements is significantly more important than price. The FDA intends to make an award immediately after the response of this notice. The award will be made in accordance with FAR Part 13, Simplified Acquisition Procedures. CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. You will need your Dun & Bradstreet number and banking information. QUESTIONS DEADLINE: All questions are to be submitted via email to: william.lee@fda.hhs.gov no later than September 18, 2009, 2009, 1:00 p.m. EST. No phone calls will be accepted. QUOTATIONS DUE: All quotations are due, via email to: william.lee@fda.hhs.gov, no later than September 18, 2009, 4:30 p.m. EST. PROVISIONS and CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. Offerors shall include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications Commercial Items. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, and FAR 52.232-33. FAR 52.217-9.Clauses and provisions are incorporated by reference and apply to this acquisition.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1062232/listing.html)
- Record
- SN01958646-W 20090919/090917235731-60b89f3b0db9c68e341b9b92ee40710c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |